Know Cancer

or
forgot password

A Randomized Controlled Trial of Light Therapy on Biomarkers, Sleep/Wake Activity, and Quality of Life in Individuals With Post-treatment Cancer-related Fatigue


N/A
18 Years
65 Years
Open (Enrolling)
Both
Cancer

Thank you

Trial Information

A Randomized Controlled Trial of Light Therapy on Biomarkers, Sleep/Wake Activity, and Quality of Life in Individuals With Post-treatment Cancer-related Fatigue


Inclusion Criteria:



- English speaking

- Non metastatic cancer

- At least 3 months post chemotherapy/radiation treatment (hormone treatment ok)

- Meets criteria for cancer-related fatigue

Exclusion Criteria:

- Under 18 years of age

- Presence of a sleep disorder other than insomnia or hypersomnia

- Shift work

- Presence of an Axis-I psychiatric condition

- Presence of a medical condition that may impact levels of fatigue

- Presence of conditions contraindicated to the use of light therapy or
photosensitizing medications

- Randomization refusal

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care

Outcome Measure:

Change in fatigue symptoms from baseline to post-treatment

Outcome Time Frame:

Baseline, after each treatment week (each week for 4 weeks), and at week 6

Safety Issue:

No

Principal Investigator

Tavis S Campbell, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Calgary

Authority:

Canada: Ethics Review Committee

Study ID:

10003569

NCT ID:

NCT01780623

Start Date:

January 2013

Completion Date:

March 2014

Related Keywords:

  • Cancer
  • fatigue
  • sleep
  • quality of life
  • light
  • cancer
  • Fatigue

Name

Location